Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | NOS3 | P29474 | 1/20 | 0.50 |
| ▸ | NOS1 | P29475 | 1/20 | 0.50 |
| ▸ | NOS2 | P35228 | 1/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TTK | P33981 | 1/20 | 0.44 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.44 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL56245 | 0.97 | HRH3 (0.61) | HRH3ALDH1A1TSHRTAAR1MAPT | |
| Hydrochloric Acid SCHEMBL1322204 | 0.97 | HRH3 (0.61) | HRH3ALDH1A1TSHRTAAR1MAPT | |
| SCHEMBL4728405 | 0.93 | HRH3 (0.77) | HRH3ALDH1A1TSHRTAAR1MAPT | |
| SCHEMBL659509 | 0.86 | HRH3 (0.82) | HRH3ALDH1A1TSHRTAAR1NOS3 | |
| SCHEMBL27532122 | 0.82 | TAAR1 (0.65) | HRH3ALDH1A1TSHRTAAR1MAOB | |
| SCHEMBL11831735 | 0.82 | AOC3 (0.62) | HRH3ALDH1A1TSHRMAPTCYP3A4 | |
| SCHEMBL4277824 | 0.80 | HRH3 (0.58) | HRH3ALDH1A1TSHRTAAR1TDP1 | |
| SCHEMBL6895864 | 0.80 | MAPT (0.48) | HRH3ALDH1A1TSHRMAPTCYP3A4 | |
| SCHEMBL3153586 | 0.80 | MAPT (0.48) | HRH3ALDH1A1TSHRMAPTCYP3A4 | |
| SCHEMBL3972958 | 0.79 | HRH3 (0.64) | HRH3ALDH1A1TSHRTAAR1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 569 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080401-A | Tertiary PTAA copolymer and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-118703186-B | Nano imbibition oil displacement agent for improving recovery ratio | 东营江源化工有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118703186-A | Nano imbibition oil displacement agent for improving recovery ratio | 东营江源化工有限公司 | 2024-09-27 | — | — | CN | claimed |
| US-20160243059-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DEGENERATIVE BRAIN DISEASE COMPRISING MULTI-TARGETING COMPOUNDS | UNIST ACADEMY-INDUSTRY RESEARCH CORPORATION (KR) | 2016-08-25 | — | — | US | claimed |
| WO-2014009318-A1 | 3-{3-[1 -(4-DIMETHYLAMINOMETHYL-PHENYLAMINO)-1 -PHENYL-METH-(Z)-YLIDENE]-2-OXO-2,3-DIHYDRO-1 H-INDOL-6-YLL-PROPYNOIC ACID ETHYLAMIDE AND ITS USE IN THE TREATMENT OF CANCER | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-01-16 | — | — | WO | claimed |
| US-20140018372-A1 | CRYSTALLINE FORM OF A INDOLINONE DERIVATIVE AND ITS USE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-01-16 | — | — | US | claimed |
| US-8354444-B2 | Substituted pyrrolidine-2-carboxamides | HOFFMANN-LA ROCHE INC. (US) | 2013-01-15 | — | — | US | claimed |
| EP-2534132-A1 | SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES | F. Hoffmann-La Roche AG (CH) | 2012-12-19 | — | — | EP | claimed |
| US-20100152190-A1 | Substituted Pyrrolidine-2-Carboxamides | F. HOFFMANN-LA ROCHE AG (CH) | 2010-06-17 | — | — | US | claimed |
| US-20080108611-A1 | SUBSTITUTED THIENOPYRIMIDINE KINASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-05-08 | — | — | US | claimed |
| WO-2007084815-A2 | SUBSTITUTED THIENOPYRIMIDINE KINASE INHIBITORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-07-26 | — | — | WO | claimed |
| CN-122080401-A | Tertiary PTAA copolymer and preparation method thereof | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4667461-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON S AND GAUCHER DISEASE | Children's Hospital Medical Center (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250382274-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S AND GAUCHER DISEASE | CHILDRENS HOSPITAL MED CT (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4067354-B1 | NOVEL TRIAZOLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | DAEWOONG PHARMACEUTICAL CO LTD (KR) | 2025-10-22 | — | — | EP | disclosed |
| US-4213898-A | FOR POLYACRYLONITRILE | SANDOZ LTD. (CH) | 1980-07-22 | — | — | US | disclosed |
| US-4193800-A | COLOR DIFFUSION TRANSFER, POLYMER HAVING ACRYLOLAMINOPHENYL AMMONIUM UNITS | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1980-03-18 | — | — | US | disclosed |
| US-4032532-A | AZO DYES | SANDOZ LTD. (CH) | 1977-06-28 | — | — | US | disclosed |
| US-3998803-A | TEXTILES | FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER THE SANDOZ TRUST (US) | 1976-12-21 | — | — | US | disclosed |
| US-3966706-A | 2,6-Dihydroxy-3-cyano-4-methylpyridine containing azo dyes which contain a functional amino group | CIBA-GEIGY AG (CH) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152190-A1 | Substituted Pyrrolidine-2-Carboxamides | ARG2, CCNY, PYCR1 | HRH3 270/4885ALDH1A1 2027/4885TSHR 846/4885 |
| US-20250382274-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S AND GAUCHER DISEASE | GBA1, GAA, GBA2 | HRH3 2598/4885ALDH1A1 1073/4885TSHR 4231/4885 |
| US-20140018372-A1 | CRYSTALLINE FORM OF A INDOLINONE DERIVATIVE AND ITS USE | PIR, IDO1, UACA | HRH3 2607/4885ALDH1A1 283/4885TSHR 2818/4885 |
| US-20080108611-A1 | SUBSTITUTED THIENOPYRIMIDINE KINASE INHIBITORS | MAP4K2, MAP3K6, MAP3K2 | HRH3 1921/4885ALDH1A1 1988/4885TSHR 2375/4885 |
| US-20160243059-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DEGENERATIVE BRAIN DISEASE COMPRISING MULTI-TARGETING COMPOUNDS | APP, PSEN1, BACE1 | HRH3 3635/4885ALDH1A1 1006/4885TSHR 3327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.